Loading
CGM / Impaired Glucose Tolerance / Prediabetes · Interventional Study
ClinicalTrials.gov · August 7, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed but unreported registry record for a small single-arm study of continuous glucose monitoring in 12 children and adolescents with impaired glucose tolerance. No results, effect sizes, or comparisons are provided in this registry entry. The study was designed to test whether real-time glucose feedback improves adherence to lifestyle modification and reduces insulin resistance, but outcomes remain unpublished in this source.
Interventional, Single Group, Open label, Prevention purpose. Impaired Glucose Tolerance, Prediabetes; age from 10 Years; to 18 Years. Intervention: CGM intervention. n = 12. 1 site: United States.
This is a completed but unreported registry record for a small single-arm study of continuous glucose monitoring in 12 children and adolescents with impaired glucose tolerance. No results, effect sizes, or comparisons are provided in this registry entry. The study was designed to test whether real-time glucose feedback improves adherence to lifestyle modification and reduces insulin resistance, but outcomes remain unpublished in this source.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
No clinical impact can be assessed from this registry entry, as no results are reported. Clinicians and researchers should seek the published trial report to evaluate the effectiveness of CGM as a behavioural intervention in this population.
This is a completed registry record for a small single-arm interventional study (n=12) testing a device-based intervention in children with impaired glucose tolerance; no results are posted in this registry entry.
As stated by the source record.
Quoted from the source exactly as published.
No clinical impact can be assessed from this registry entry, as no results are reported. Clinicians and researchers should seek the published trial report to evaluate the effectiveness of CGM as a behavioural intervention in this population.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05387551). This is a study registration, not published results. Lead sponsor: Nemours Children's Clinic. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 12 participants (ACTUAL). Conditions: Impaired Glucose Tolerance, Prediabetes. Interventions: DEVICE: CGM. Primary outcome measures: Insulin Sensitivity Score (ISS) , Baseline to 6 months. Brief summary: The incidence of type 2 diabetes (T2D) in children is increasing, paralleling the rising incidence of obesity. Preventing children and adolescents from developing T2D is critical. The health benefits of lifestyle modifications are well documented in this population, but success rates are low. Obesity in children and adolescents increases the risk of not only T2D but other complications as well, such as hypertension, dyslipidemias and more. The investigators hypothesize that having real-time glucose data with the use of a continuous glucose monitor (CGM) in obese patients with impaired glucose tolerance will improve adherence to lifestyle modifications. As a result, a decrease in body mass index (BMI) is expected with subsequent improvement in insulin sensitivity, thus reducing risk of obesity-related complications later in childhood/adolescence and adulthood.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.